Načítá se...
Mineralocorticoid receptor antagonist use following heart failure hospitalization
AIMS: Patients hospitalized for heart failure (HF) are at increased risk for events post‐discharge. Mineralocorticoid receptor antagonists (MRAs) improve the clinical course of patients with HF with reduced ejection fraction. We assessed MRA use in high‐risk patients following an HF hospitalization...
Uloženo v:
| Vydáno v: | ESC Heart Fail |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7160481/ https://ncbi.nlm.nih.gov/pubmed/32035000 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12635 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|